Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your Wegovy solution looks brown or darker than expected, the short answer is this: a pale yellow or faintly amber tint is within the normal range for semaglutide solution, and a slightly deeper golden hue does not automatically mean the pen is faulty or unsafe. What matters is knowing the difference between acceptable variation and a genuine reason to discard it — and that distinction is clearer than most people expect. Wegovy is a prescription-only medicine, so any genuine uncertainty about your pen's appearance is worth raising with your prescribing team before you inject.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The worry is understandable. You pull your pen out of the fridge, hold it to the light, and the liquid looks more amber than the clear-to-pale-yellow you were expecting. The instinct is to assume something has gone wrong. In practice, semaglutide solution naturally sits toward the yellow end of the spectrum, and under some lighting conditions (particularly warm incandescent bulbs) that yellow reads as distinctly golden or even faintly brown. The solution has not degraded simply because it looks deeper in colour than a photograph on a website suggested it would.
That said, letting this misconception go does not mean ignoring the pen's appearance entirely. It means calibrating your expectations correctly so that you can spot genuine problems without panicking at a normal one. The Patient Information Leaflet, which ships with every pen and is also published on the Wegovy SmPC on the eMC, describes what an acceptable solution looks like and explicitly tells you when to discard the pen. Reading that section once, properly, is genuinely useful.
If the solution is cloudy, has visible particles floating in it, or the colour is clearly dark brown rather than a light amber, those are different matters. Discard the pen and speak to your prescriber. The line between "looks a bit yellow" and "looks wrong" is real, even if it requires a moment's attention to draw.
Semaglutide is a peptide molecule, and like most peptides it is sensitive to temperature. Wegovy pens are licensed for storage in a refrigerator between 2°C and 8°C. Once removed, they can be kept at room temperature for a limited period, the exact window for which is set out in the SmPC, always check the leaflet rather than relying on a figure you have seen online, because the details matter.
Where temperature becomes relevant to colour is when a pen has been exposed to heat beyond that permitted range: left in a warm car, placed near a radiator, or stored in a bag in direct sunlight. Heat can accelerate degradation of the active ingredient and change the solution's appearance, sometimes producing a darker or cloudier result. A pen that has experienced a cold-chain break should not be used even if it still looks broadly normal, because appearance alone is not a reliable indicator of whether the medicine remains potent and safe.
Freezing is equally damaging. A pen that has frozen (even briefly) should be discarded. For practical guidance on travelling with Wegovy and keeping pens within their safe temperature window, the Wegovy patient guide covers storage in everyday terms. The NHS's patient information for semaglutide also addresses storage under the NHS semaglutide medicines page, which is worth bookmarking.
Building a brief visual check into your weekly injection routine takes about fifteen seconds and removes most of the uncertainty around pen appearance. Hold the pen up to a clear light source, daylight or a white LED is more reliable than warm ambient lighting. The solution should be clear or pale yellow, free of particles, and without any cloudiness or obvious dark discolouration.
While you are doing this, also check the expiry date printed on the pen and confirm that you are using the right strength for your current dose, something that matters particularly when you are mid-titration. If anything looks off, the right move is to contact your prescriber rather than inject and hope. Most concerns can be resolved quickly.
It is also worth knowing that a pen reaching the end of its dose window will show the plunger has moved; this is expected and not a sign of damage. What you are looking for in the visual check is the solution itself, not the mechanics of the pen.
If you are new to Wegovy or still weighing up how it works as a treatment, the overview on how Wegovy is used for weight management gives broader context. For a fuller picture of semaglutide as a medicine, including how it acts on appetite, the semaglutide treatment page covers the mechanism clearly. And if you are curious whether Wegovy breaks down stored fat directly or works differently, this page on how Wegovy affects fat addresses that specifically.
If you inject solution that looked abnormal and then feel unwell, contact a healthcare professional promptly. Symptoms worth taking seriously include severe or persistent stomach pain that radiates toward the back, which can be a sign of pancreatitis, the MHRA highlighted this as a known but uncommon risk in a Drug Safety Update for GLP-1 medicines. Any allergic reaction, difficulty breathing, or significant swelling also warrants urgent attention.
If you have concerns about a pen's appearance that suggest it may be counterfeit or have come from an unverified source, you can report it directly through the MHRA's Yellow Card scheme, which covers both suspected side effects and suspect medicines. The MHRA takes reports of fake pens seriously, and reporting helps protect others.
For anyone currently exploring semaglutide as an option for weight management (or wondering about the cost and process of accessing it through a registered online pharmacy) our weight loss treatments page sets out the full picture, and how to access Wegovy through a licensed UK pharmacy explains the prescription process. If you have a question that is not answered here, our team is reachable through our contact page. Speaking to our prescribers is the right first step for any concern that is specific to your pen or your dose. If you have come across Wegovy referred to by other names and want to understand why, our page on what Wegovy is also known as explains the different terms you may encounter.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.